NSC 366140 [clinicaltrials_resource:5a7945e72150dc59a621651fafa8f177]
Pyrazoloacridine in Treating Women With Metastatic Breast Cancer [clinicaltrials:NCT00002585]clinicaltrials:NCT00002656Pyrazoloacridine in Treating Women With Refractory Metastatic Breast Cancer [clinicaltrials:NCT00003041]Chemotherapy in Treating Patients With Unresectable Primary or Metastatic Kidney Cancer [clinicaltrials:NCT00003714]Pyrazoloacridine in Treating Patients With Metastatic Skin or Eye Melanoma [clinicaltrials:NCT00003802]Pyrazoloacridine Plus Carboplatin in Treating Patients With Recurrent Glioma [clinicaltrials:NCT00005976]Pyrazoloacridine Followed by Radiation Therapy in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme [clinicaltrials:NCT00006355]Pyrazoloacridine and Stem Cell or Bone Marrow Transplantation in Treating Young Patients With High-Risk Neuroblastoma [clinicaltrials:NCT00053950]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
NSC 366140 [clinicaltrials_resource:5a7945e72150dc59a621651fafa8f177]
Bio2RDF identifier
5a7945e72150dc59a621651fafa8f177
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:5a7945e72150dc59a621651fafa8f177
identifier
clinicaltrials_resource:5a7945e72150dc59a621651fafa8f177
title
NSC 366140
@en
type
label
NSC 366140 [clinicaltrials_resource:5a7945e72150dc59a621651fafa8f177]
@en